Menu
Recruiting NCT07309263

Comparing the Effects of Smart App-Assited Super-Slow Jogging and Stationary Cycling on Respiratory Function and Aerobic Fitness in College Students

No phase Interventional Sedentary Lifestlye Young Adult

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Super slow jogging, moderate exercise training, Control.
Who it may be relevant to
Registry conditions: Sedentary Lifestlye, Young Adult. Basic parameters: 18 years — 25 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

As health awareness continues to rise, more people are prioritizing exercise to improve physical condition and enhance overall fitness. For those lacking exercise habits, selecting a simple, accessible, and effective workout becomes crucial. Against a backdrop of prolonged sitting and inactivity, "super slow jogging" is gaining attention. This aerobic exercise involves a slow walking pace and low intensity, yet burns more calories than regular walking, making it an ideal entry-level activity for beginners or those with lower fitness levels. This study aims to investigate whether incorporating super slow jogging training can effectively enhance cardiorespiratory fitness and respiratory function, comparing its outcomes with other exercise types. The purpose of this experiment is academic research, primarily exploring the impact of exercise intervention on physiological functions. It is not intended for health screening or medical diagnosis.

Interventions

  • Behavioral Super slow jogging
    This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekl
  • Behavioral moderate exercise training
    This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekl
  • Behavioral Control
    This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekl

Primary outcome measures

  • Cardiopulmonary Fitness [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Baseline anthropometric of the participants [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Cardiopulmonary Fitness [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Cardiopulmonary Fitness [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Cardiopulmonary Fitness [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Cardiopulmonary Fitness [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Cardiopulmonary Fitness [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Cardiopulmonary Fitness [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Baseline anthropometric of the participants [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Baseline anthropometric of the participants [Time frame: Before intervention and the end of intervention at 12 weeks]
Secondary outcome measures (8)
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]
  • Lung function [Time frame: Before intervention and the end of intervention at 12 weeks]

Eligibility criteria

Inclusion criteria

  • required no regular exercise training in the past six months
  • ability to safely perform high-intensity cycling exercise

Exclusion criteria

  • musculoskeletal limitations that prevented cycling exercise
  • recent infection
  • known cardiopulmonary disease or medical history affecting cardiovascular or respiratory function
  • smoking
  • use of medications that may influence cardiopulmonary responses to exercise
  • other contraindications to exercise testing according to the American College of Sports Medicine (ACSM) guidelines

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Taiwan · 1 center
  • No. 151, Jinxue Rd. — Kaohsiung City

Identifiers

NCT: NCT07309263 · 114-0561 · 114-2813-C-242-003-B

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗